Farmakokinetikken for ibandronsyre blev ikke undersøgt hos patienter med terminal nyresygdom behandlet med andet end hæmodialyse.
The pharmacokinetics of ibandronic acid was not assessed in patients with end-stage renal disease managed by other than hemodialysis.